Determining the Possibility of Using a Functional Dairy Product in the Dietary Therapy of Irritable Bowel Syndrome and Metabolic Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07793487

Title field or adapter rule

{'original_value': 'Determining the Possibility of Using a Functional Dairy Product in the Dietary Therapy of Irritable Bowel Syndrome and Metabolic Syndrome', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.951721+00:00

Published At

2026-08-28T00:00:00+00:00

Record Updated At

2026-08-28

Source Retrieved At

2026-10-31T22:18:48.933435+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Metabolic Syndrome", "IBS - Irritable Bowel Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-08-28", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07793487"

protocolSection.identificationModule.officialTitle

"Determining the Possibility of Using a Functional Dairy Product in the Dietary Therapy of Irritable Bowel Syndrome and Metabolic Syndrome"

protocolSection.statusModule.overallStatus

"ENROLLING_BY_INVITATION"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Metabolic Syndrome (protocolSection.conditionsModule.conditions)
• IBS - Irritable Bowel Syndrome (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['MS and IBS receiving new functional milk drink'], 'description': 'The study will use a fermented milk drink with the characteristics of sour milk, with the addition of a selected strain of lactic acid bacteria, with potential properties influencing not only peristalsis but also the metabolism of people with abdominal obesity.\n\nThe milk drinks will be prepared based on technology developed as part of the SupRim project by the teams of Institute of Food and Nutrition, SGGW. Milk will then be inoculated with Levilactobacillus brevis B1 bacteria (2.5g of freeze-dried bacteria with a count of 1010 CFU/g per 100 liters of milk). The Levilactobacillus brevis B1 strain comes from the collection of the Department of Gastronomic Technology and Food Hygiene at the Institute of Food and Agriculture, SGGW. This strain inhibits the growth of pathogenic bacteria of the species Listeria monocytogenes, Bacillus subtilis, E. coli, Enterococcus feacium and Salmonella enteritidis (Patent No.: P.426002/UP RP: Zielińska et all, 2020).', 'name': 'new functional milk drink', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['people with MS and IBS receiving conventional, acidified milk drink'], 'description': 'The study will use a conventional milk drink with the characteristics of sour milk, with the addition of a selected strain of commercially available lactic acid bacteria, produced as sour milk by Dorota Wesołek: Wesoła Zagroda.', 'name': 'conventional, acidified milk drink', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.